Compare BBDC & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBDC | AVNS |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Financial Services | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 962.2M | 521.7M |
| IPO Year | 2007 | N/A |
| Metric | BBDC | AVNS |
|---|---|---|
| Price | $9.17 | $13.10 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.67 | N/A |
| AVG Volume (30 Days) | ★ 559.3K | 536.6K |
| Earning Date | 02-19-2026 | 02-25-2026 |
| Dividend Yield | ★ 11.37% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | $281,866,000.00 | ★ $699,900,000.00 |
| Revenue This Year | N/A | $3.07 |
| Revenue Next Year | N/A | $2.16 |
| P/E Ratio | $9.49 | ★ N/A |
| Revenue Growth | N/A | ★ 2.70 |
| 52 Week Low | $7.66 | $9.30 |
| 52 Week High | $10.85 | $17.69 |
| Indicator | BBDC | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 52.68 | 68.90 |
| Support Level | $9.00 | $12.12 |
| Resistance Level | $9.31 | $13.31 |
| Average True Range (ATR) | 0.16 | 0.47 |
| MACD | -0.00 | 0.14 |
| Stochastic Oscillator | 54.37 | 91.09 |
Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. Barings employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.